Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results.
Guckenberger, Matthias
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. [electronic resource] - Radiation oncology (London, England) Dec 2009 - 67 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1748-717X
10.1186/1748-717X-4-67 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Combined Modality Therapy
Digestive System Surgical Procedures
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoadjuvant Therapy--adverse effects
Neoplasm Staging
Radiotherapy--adverse effects
Radiotherapy Dosage
Rectal Neoplasms--mortality
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. [electronic resource] - Radiation oncology (London, England) Dec 2009 - 67 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1748-717X
10.1186/1748-717X-4-67 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Combined Modality Therapy
Digestive System Surgical Procedures
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoadjuvant Therapy--adverse effects
Neoplasm Staging
Radiotherapy--adverse effects
Radiotherapy Dosage
Rectal Neoplasms--mortality